Loading...

Home
ETF
FHTX

FHTX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

FHTX News

Foghorn Therapeutics to Participate in Biotech Summit

Feb 03 2026Newsfilter

Atossa Therapeutics Receives FDA Orphan Drug Designation, Stock Rises Nearly 13%

Jan 20 2026NASDAQ.COM

Oncolytics Biotech Accelerates Cancer Treatment with New Executive Appointments

Jan 14 2026Newsfilter

Oncolytics Biotech Accelerates Cancer Treatment Progress, Aiming for FDA Approval in 2026

Jan 14 2026PRnewswire

Foghorn Therapeutics Raises $50 Million to Advance Cancer Treatments

Jan 10 2026Globenewswire

Foghorn Therapeutics Raises $50 Million to Advance Cancer Treatments

Jan 10 2026Newsfilter

GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4

Dec 11 2025Newsfilter

GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 at 10μg/kg/day

Dec 11 2025PRnewswire

Stifel Nicolaus Begins Coverage of Foghorn Therapeutics, Assigns Buy Rating and $12 Price Target

Dec 04 2025Yahoo Finance

Aardvark Therapeutics Analyst Starts Coverage Optimistically; Check Out the Top 3 Initiations for Friday

Nov 07 2025Benzinga

Foghorn Therapeutics Set to Attend Three Upcoming Investor Conferences

Nov 03 2025Newsfilter

Foghorn Therapeutics Reports Major Advancements for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit

Oct 16 2025Newsfilter

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

Aug 28 2025PRnewswire

Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering

Aug 11 2025Newsfilter

Flagship Pioneering Unveils Terrana Biosciences to Deliver Adaptive, Targeted Agricultural Solutions through a Novel RNA Technology Platform

Jul 01 2025Newsfilter

Ted Myles Joins Cellarity as Chief Executive Officer

May 12 2025Newsfilter